Globus Medical, Inc. (NYSE: GMED) reported Q3 EPS of $0.18, $0.01 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $94.76 million versus the consensus estimate of $95.32 million.

For earnings history and earnings-related data on Globus Medical, Inc. (GMED) click here.

Earnings